In HCC, CAFs induce indoleamine 2,3-dioxygenase(IDO)-producing regulatory DCs to acquire a tolerogenic phenotype through IL6-mediated STAT3 activation (64). Here, IDO2 is linked to hepatocellular carcinoma.